GKWIM
BIIB icon

Gerber Kawasaki Wealth & Investment Management’s Biogen BIIB Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed -$14K – 375
2021
Q3 		$14K Buy
+50
New +$16.4K ﹤0.01% 574

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's BIIB Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 50 shares — an estimated $14K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in BIIB in Q3 2021 and held it in 1 quarter. The position peaked at $14K in Q3 2021. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 50 Biogen shares in Q4 2021, an estimated $14K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Biogen in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Biogen position peaked at $14K in Q3 2021.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.